Seegene, Inc. and Selventa Form Strategic Collaboration to Develop Novel Molecular Diagnostics (MoDx)
4/23/2013 11:55:06 AM
More...
|
Seegene, Inc. Signs New License Agreement for DPO™and TOCE™Technologies
4/15/2013 9:24:49 AM
More...
|
Seegene, Inc. Names John G. Hurrell as Senior Executive Vice President
1/14/2013 9:48:24 AM
More...
|
Seegene, Inc. Licenses DPO™ and TOCE™ Technologies to DuPont (DD) for Food Safety Testing
12/10/2012 9:43:38 AM
More...
|
Seegene, Inc. to Participate in High Profile Panel on Companion Diagnostics at BIO-Europe 2012
11/8/2012 8:46:22 AM
More...
|
Seegene, Inc. to Unveil Groundbreaking Technology for Highly Multiplexed Quantitative Real-Time Molecular Assays at American Association for Clinical Chemistry 2012
7/11/2012 8:51:40 AM
More...
|
Seegene, Inc. to Introduce Real-Time Multiple Mutation Detection Technology for Drug Resistant Mutations in M. Tuberculosis at American Association for Clinical Chemistry 2012
7/2/2012 8:44:14 AM
More...
|
Seegene, Inc. Introduces the First Real Time Multiplex Quantification Test for Human Papilloma Virus (HPV)
6/25/2012 9:45:44 AM
More...
|
Seegene, Inc. Introduces the Industry's First Real-Time Multiplex Quantification Assay for Respiratory Diseases
6/18/2012 9:08:01 AM
More...
|
Seegene, Inc. Develops Industry's First Real-Time "Multiplex Quantification" Molecular Diagnostic Testing Technology
5/30/2012 8:53:35 AM
More...
|
|